Abiopharma

News list

EPSTEIN ROBERT S 🟢 acquired 50.0K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $1.69 Transaction Date: May 05, 2026 | Filing ID: 208899

Full text

News bot May 6, 2026, 8:02 p.m.
🔍 EPSTEIN ROBERT S (Executive)

Company: FATE THERAPEUTICS INC (FATE)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 50,000
Detailed Transactions and Holdings:
- Acquired 25,000 shares of Common Stock at $1.69 per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 36,331.00 | transaction_form_type: 4
- Acquired 25,000 shares of Stock Option (Right to Buy) at $1.69 per share (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2026-05-11 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares subject to the option vested and became exercisable on the date of the 2017 Annual Meeting of Stockholders.